Format

Send to

Choose Destination
Biomedicine (Taipei). 2019 Dec;9(4):27. doi: 10.1051/bmdcn/2019090427. Epub 2019 Nov 14.

The RNA degradation pathway is involved in PPARα-modulated anti-oral tumorigenesis.

Author information

1
Department of Biochemistry, College of Medicine, China Medical University, Taichung 404, Taiwan.
2
Department of Physiology, College of Medicine, China Medical University, Taichung 404, Taiwan.

Abstract

BACKGROUND:

The activation of peroxisome proliferator-activated receptor alpha (PPARα) has been shown to reprogram tumor metabolism and exhibits great potential for treating anti-oral tumorigenesis.

METHODS:

In this study, we used a pathway-based strategy to explore possible functional pathways involved in the anticancer activity of PPARα in oral cancer cells through next-generation sequencing (NGS) and bioinformatic approaches.

RESULTS:

We found that 3919 genes were upregulated and 1060 genes were downregulated through PPARα activation. These genes were mainly involved in the proteasomal, mRNA surveillance, spliceosomal, RNA transport, and RNA degradation pathways, as indicated by GO and KEGG enrichment analysis. Importantly, a total of 13 upregulated genes in the RNA degradation pathway were identified including 3 core exosome factor genes (RRP43, RRP42, and CSL4), 2 TRAMP complex genes (TRF4 and Mtr4), 2 exosome cofactor genes (RRP6 and MPP6), 2 CCR4-NOT complex genes (CNOT2 and CNOT3), 2 Ski complex genes (SKI2 and Ski3), 1 decapping complex gene (EDC4), and 1 gene involved in 5' exoribonuclease activity (XRN1).

CONCLUSION:

Our findings suggest that the activation of PPARα to upregulate the RNA degradation pathway might provide a new strategy for oral cancer treatment.

KEYWORDS:

Next-generation sequencing; Oral cancer; PPARα; RNA degradation pathway

Supplemental Content

Full text links

Icon for EDP Sciences Icon for PubMed Central
Loading ...
Support Center